Skip to content

Postprandial Effects of Functional Bread

Postprandial Effects of Functional Bread

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04289545
Enrollment
12
Registered
2020-02-28
Start date
2019-11-01
Completion date
2021-07-07
Last updated
2021-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial Hyperglycemia

Brief summary

This study investigates whether bread with added galactomannan, a soluble fiber, can reduce the postprandial glucose response in healthy overweight adults.

Detailed description

This single-blind crossover-designed study wants to investigate the postprandial effect of functional bread in healthy overweight adults. Therefore, four types of bread, consumed by the participants, have added galactomannan in different amounts and viscosities, and one bread is the control bread. The participants arrive after an overnight fast and before the consumption of bread, a fasting blood sample is taken. After the ingestion, blood samples are taken at specific times. The area under the curve of the postprandial glucose is expected to differ between the functional breads.

Interventions

DIETARY_SUPPLEMENTFunctional bread

Postprandial effects of bread containing galactomannan

Sponsors

University of Bergen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy, overweight adults (BMI between 25 and 30 kg/m2)

Exclusion criteria

* Known diagnosis of diabetes mellitus type 2 * HbA1c at screening ≥ 48 mmol/mol * Other chronic diseases (heart disease, cancer) within the last 3 years * Pregnancy and lactation * Known drug or alcohol abuse * Unwilling to follow the study requirements

Design outcomes

Primary

MeasureTime frame
area under the curve of postprandial glucose180 minutes

Secondary

MeasureTime frame
area under the curve postprandial insulin180 minutes

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026